DE69832982D1 - Dolastatin 15 derivate - Google Patents

Dolastatin 15 derivate

Info

Publication number
DE69832982D1
DE69832982D1 DE69832982T DE69832982T DE69832982D1 DE 69832982 D1 DE69832982 D1 DE 69832982D1 DE 69832982 T DE69832982 T DE 69832982T DE 69832982 T DE69832982 T DE 69832982T DE 69832982 D1 DE69832982 D1 DE 69832982D1
Authority
DE
Germany
Prior art keywords
dolastatine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832982T
Other languages
English (en)
Other versions
DE69832982T2 (de
Inventor
Bernd Janssen
Teresa Barlozzari
Andreas Haupt
Thomas Zierke
Andreas Kling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Publication of DE69832982D1 publication Critical patent/DE69832982D1/de
Application granted granted Critical
Publication of DE69832982T2 publication Critical patent/DE69832982T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69832982T 1997-07-18 1998-07-07 Dolastatin 15 derivate Expired - Lifetime DE69832982T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US896394 1997-07-18
US08/896,394 US6143721A (en) 1997-07-18 1997-07-18 Dolastatin 15 derivatives
PCT/US1998/013901 WO1999003879A1 (en) 1997-07-18 1998-07-07 Dolastatin 15 derivatives

Publications (2)

Publication Number Publication Date
DE69832982D1 true DE69832982D1 (de) 2006-02-02
DE69832982T2 DE69832982T2 (de) 2006-08-24

Family

ID=25406130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832982T Expired - Lifetime DE69832982T2 (de) 1997-07-18 1998-07-07 Dolastatin 15 derivate

Country Status (33)

Country Link
US (6) US6143721A (de)
EP (1) EP0991658B1 (de)
JP (4) JP4508413B2 (de)
KR (1) KR100579748B1 (de)
CN (1) CN1268636C (de)
AR (1) AR018501A1 (de)
AT (1) ATE314387T1 (de)
AU (1) AU750120B2 (de)
BG (1) BG65212B1 (de)
BR (1) BR9810911A (de)
CA (1) CA2296036C (de)
CO (1) CO4990967A1 (de)
CY (1) CY1107047T1 (de)
CZ (1) CZ303045B6 (de)
DE (1) DE69832982T2 (de)
DK (1) DK0991658T3 (de)
ES (1) ES2258819T3 (de)
HK (1) HK1029125A1 (de)
HR (1) HRP980397A2 (de)
HU (1) HU228996B1 (de)
ID (1) ID24669A (de)
IL (1) IL133784A (de)
MY (1) MY135057A (de)
NO (1) NO326827B1 (de)
NZ (1) NZ502296A (de)
PL (1) PL197884B1 (de)
PT (1) PT991658E (de)
RU (1) RU2195462C2 (de)
SK (1) SK286581B6 (de)
TR (2) TR200000132T2 (de)
TW (1) TW533217B (de)
WO (1) WO1999003879A1 (de)
ZA (1) ZA986358B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
AU2001227375A1 (en) * 2000-02-08 2001-08-20 Herbert T. Nagasawa N-terminal d(-)-penicillamine peptides as aldehyde sequestration agents
US7256257B2 (en) * 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
JP5042444B2 (ja) * 2002-03-22 2012-10-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 癌の処置におけるヘミアスタリン誘導体およびその利用法
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
PT1545613E (pt) * 2002-07-31 2011-09-27 Seattle Genetics Inc Conjugados de auristatina e sua utilização para tratamento do cancro, de uma doença autoimune ou de uma doença infecciosa
SG10201701737XA (en) 2003-11-06 2017-04-27 Seattle Genetics Inc Monomethylvaline compounds capable of conjugation to ligands
WO2006063135A2 (en) * 2004-12-09 2006-06-15 Eisai R & D Management Co., Ltd. Tubulin isotype screnning in cancer therapy using hemiasterlin analogs
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Ｂｉｒドメイン結合化合物
EP2024362A4 (de) 2006-05-16 2012-01-25 Pharmascience Inc An die iap-bir-domäne bindende verbindungen
SG183023A1 (en) 2007-07-16 2012-08-30 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
RU2557319C2 (ru) 2007-07-16 2015-07-20 Дженентек, Инк. ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ CD79b И ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ПРИМЕНЕНИЯ
DE102007039706A1 (de) 2007-08-22 2009-02-26 Erhard Prof. Dr.-Ing. Kohn Chemischer Sensor auf Diamantschichten
WO2009099728A1 (en) 2008-01-31 2009-08-13 Genentech, Inc. Anti-cd79b antibodies and immunoconjugates and methods of use
NZ600608A (en) * 2009-12-18 2015-01-30 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
MX341687B (es) 2010-02-10 2016-08-30 Immunogen Inc "anticuerpos cd20 y su utilización".
US9284350B2 (en) 2010-02-12 2016-03-15 Pharmascience Inc. IAP BIR domain binding compounds
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
PT3122757T (pt) 2014-02-28 2023-11-03 Hangzhou Dac Biotech Co Ltd Ligantes carregados e as suas utilizações em conjugação
AU2015320678B2 (en) 2014-09-23 2021-07-22 Genentech, Inc. Method of using anti-CD79b immunoconjugates
EP3319936A4 (de) 2015-07-12 2019-02-06 Suzhou M-conj Biotech Co., Ltd. Brückenlinker zur konjugation von zellbindenden molekülen
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
JP7138350B2 (ja) 2016-11-14 2022-09-16 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． 共役連結体、該連結体を含有する細胞結合分子－薬物共役体、並びに該共役体及び連結体の使用及び製造方法
JPWO2023033129A1 (de) 2021-09-03 2023-03-09

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
EP0598129B1 (de) * 1991-08-09 2000-03-22 Teikoku Hormone Mfg. Co., Ltd. Neue tetrapeptidderivate
US5533097A (en) * 1992-02-26 1996-07-02 Motorola, Inc. Portable communication system comprising a local and wide area communication units which can store a communication when the wide area communication system is not available
WO1993017388A1 (en) * 1992-02-26 1993-09-02 Clark Paul C System for protecting computers via intelligent tokens or smart cards
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
AU679479B2 (en) * 1992-12-16 1997-07-03 Basf Aktiengesellschaft Dolostatin analog
US5554993A (en) * 1994-01-04 1996-09-10 Panasonic Technologies, Inc. Global position determining system and method
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5554725A (en) * 1994-09-14 1996-09-10 Arizona Board Of Regents Acting On Behalf Of Arizona State University Synthesis of dolastatin 15
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5618232A (en) * 1995-03-23 1997-04-08 Martin; John R. Dual mode gaming device methods and systems
US5970143A (en) * 1995-11-22 1999-10-19 Walker Asset Management Lp Remote-auditing of computer generated outcomes, authenticated billing and access control, and software metering system using cryptographic and other protocols
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
AU728161B2 (en) * 1997-01-10 2001-01-04 Silicon Gaming, Inc. Method and apparatus using geoographical position and a universal time to determination means to provide authenticated, secure, on-line communication between remote gaming locations
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6554705B1 (en) * 1997-08-22 2003-04-29 Blake Cumbers Passive biometric customer identification and tracking system
US6629591B1 (en) * 2001-01-12 2003-10-07 Igt Smart token
US6438382B1 (en) * 2001-02-14 2002-08-20 Telefonaktiebolaget Lm Ericsson (Publ.) Expedited location determination in analog service areas

Also Published As

Publication number Publication date
NZ502296A (en) 2002-02-01
EP0991658A1 (de) 2000-04-12
BG65212B1 (bg) 2007-07-31
WO1999003879A1 (en) 1999-01-28
SK286581B6 (sk) 2009-01-07
KR100579748B1 (ko) 2006-05-15
US7084110B2 (en) 2006-08-01
CN1264388A (zh) 2000-08-23
US7662786B2 (en) 2010-02-16
CY1107047T1 (el) 2012-09-26
JP2012211164A (ja) 2012-11-01
JP4508413B2 (ja) 2010-07-21
JP2001515010A (ja) 2001-09-18
TR200000132T2 (tr) 2000-05-22
NO20000231L (no) 2000-01-17
US20130046077A1 (en) 2013-02-21
BG104089A (en) 2000-12-29
IL133784A (en) 2005-09-25
PL197884B1 (pl) 2008-05-30
US20030153505A1 (en) 2003-08-14
HRP980397A2 (en) 1999-04-30
HK1029125A1 (en) 2001-03-23
AU8475898A (en) 1999-02-10
US6458765B1 (en) 2002-10-01
IL133784A0 (en) 2001-04-30
CA2296036A1 (en) 1999-01-28
ID24669A (id) 2000-07-27
CZ2000176A3 (en) 2001-06-13
TR200103545T2 (tr) 2002-06-21
US6143721A (en) 2000-11-07
SK187999A3 (en) 2000-09-12
TW533217B (en) 2003-05-21
ATE314387T1 (de) 2006-01-15
PT991658E (pt) 2006-05-31
BR9810911A (pt) 2000-08-01
PL338144A1 (en) 2000-09-25
DK0991658T3 (da) 2006-05-15
AR018501A1 (es) 2001-11-28
ES2258819T3 (es) 2006-09-01
CZ303045B6 (cs) 2012-03-07
CN1268636C (zh) 2006-08-09
KR20010021998A (ko) 2001-03-15
US20100099843A1 (en) 2010-04-22
CO4990967A1 (es) 2000-12-26
US20060270606A1 (en) 2006-11-30
US8163698B2 (en) 2012-04-24
MY135057A (en) 2008-01-31
ZA986358B (en) 2000-01-17
RU2195462C2 (ru) 2002-12-27
HUP0004234A3 (en) 2001-08-28
NO326827B1 (no) 2009-02-23
JP5047935B2 (ja) 2012-10-10
HU228996B1 (hu) 2013-07-29
AU750120B2 (en) 2002-07-11
CA2296036C (en) 2007-05-01
NO20000231D0 (no) 2000-01-17
HUP0004234A2 (hu) 2001-05-28
JP2009137968A (ja) 2009-06-25
DE69832982T2 (de) 2006-08-24
EP0991658B1 (de) 2005-12-28
JP2009137967A (ja) 2009-06-25
JP5122429B2 (ja) 2013-01-16

Similar Documents

Publication Publication Date Title
DE69832982D1 (de) Dolastatin 15 derivate
DE69613368D1 (de) Chinazolin derivate
DE69613369T2 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
DE69706292D1 (de) Chinazoline derivate
DE69818665D1 (de) 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromycin a derivate
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
NO996108D0 (no) 9-oksinerytromycinderivater
DE69631774D1 (de) 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
FR2763953B1 (fr) Derives de 5'-desoxy-cytidine
NO992059D0 (no) 2-metoksyfenylpiperazinderivater
PT1060183E (pt) Derivados de 5'-desoxicitidina
DE69805974D1 (de) 5-aroylnaphthalin derivate
DE69926606D1 (de) Plazentaprotein 13
BR9709521A (pt) "3-Cianoaril-pirazóis"
DK1077984T3 (da) 2'-Deoxyhygromycin derivater
DE69709802D1 (de) Amythiamicin Amid-Derivate
MA26481A1 (fr) Derives d'arylsecocholadiene
NO996127D0 (no) 13-dihydro-3'-aziridino-antracykliner
DE69430899T2 (de) Spiropyrone Derivate
NO972978D0 (no) Tomrock 5000
SE9603412D0 (sv) 10 seconds
SE9601982D0 (sv) Tifaret 6

Legal Events

Date Code Title Description
8364 No opposition during term of opposition